Rapid blood clearance of injected mouse IgG2a in SCID mice.

SCID mice were found to have rapid blood clearance of injected mouse IgG2a antibodies (Ab), while IgG1 Ab were cleared normally. This effect varied depending on the strain of SCID mice, being very rapid in most Taconic ICR mice and slower in C.B-17 mice. A similar effect was previously described in nude mice, and shown to be due to the very low concentrations of endogenous IgG2a and IgG2b in these mice. Therefore, IgG2a and IgG2b concentrations were assayed in sera from 30 SCID mice: the concentrations were very low, with one exception. Rapid blood clearance in all strains could be strongly inhibited by injection of large amounts of irrelevant IgG2a. Therefore, the low endogenous IgG2a and IgG2b concentrations are responsible for the rapid blood clearance rate of injected IgG2a in these mice, as in nude mice. However, the relatively slow blood clearance of injected IgG2a in certain SCID mice (C.B-17 mice and rare Taconic ICR mice), was not generally due to higher levels of IgG2a or IgG2b, but rather to some other factor that has not been identified. F(ab')(2) Ab fragments were not cleared rapidly, which supports other evidence that clearance is via the CD64 Fcgamma receptor. This rapid clearance of IgG2a affects the ability of such Ab to target tumors, and was also shown to affect the maximum tolerated dose (MTD) of radiolabeled IgG2a Ab, labeled with either (125)I or (111)In. Mice with faster blood clearance had a lower MTD, probably due to the fact that Ab uptake was in the bone as well as the spleen. This effect must be taken into consideration in experiments in which SCID mice are injected with IgG2a or IgG2b Ab.